WithdrawnPhase 3

An Investigational Drug Study in Healthy Adult Volunteers in a Model of Insomnia (0928-007)

0Started 2005-01

Plain-language summary

A study to evaluate the safety and effectiveness of an investigational drug for insomnia (a sleep disorder).

Who can participate

Age range18 Years – 64 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Healthy adults who are between the ages of 18 and 64 Exclusion Criteria: * Adults who are diagnosed with insomnia

What they're measuring

4-hour advanced polysomnographic (PSG) recording session measuring wake time after sleep onset (WASO) and latency to persistent sleep (LPS); Safety and tolerability

Trial details

NCT IDNCT00102154

SponsorH. Lundbeck A/S

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

View on ClinicalTrials.gov More Insomnia trials